We assessed the efficacy of prophylactic catheter ablation in patients with sustained ventricular tachycardia (VT) and structural heart disease (SHD). Methods: 135 consecutive patients with sustained VT and SHD (ischemic cardiomyopathy (ICM), n=55 and non-ischemic cardiomyopahty (NICM), n=80), received an implantable cardioverter defi brillator (ICD), were assessed retrospectively. We compared the clinical outcome in patients undergoing VT ablation before ICD (ABL group) with patients received ICD alone (ICD group). Successful ablation was defi ned as non-inducibility of clinical VT. Appropriate ICD therapy (shock and antitachycardia pacing) during follow-up was evaluated in both group. Results: VT ablation was performed in 19 of 55 patients with ICM and in 36 of 80 patients with NICM, and succeeded in 12 of ICM, in 17 of NICM. In NICM patients, the time to fi rst appropriate shock therapy and electrical storm (ES) are significantly longer in the successful ABL group than ICD group (p=0.030, p=0.047). Hazard ratio of ES was lower in NICM than in ICM (0.45 and.1.68). Conclusion: Prophylactic catheter ablation can prolong time to fi rst shock therapy and reduce electrical storm in patients with NICM.
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